The Journal of Immunology, Vol 157, Issue 2 643-649, Copyright © 1996 by American Association of Immunologists

ARTICLES

The effect of IL-2 treatment on transcriptional attenuation in proto- oncogenes pim-1 and c-myb in human thymic blast cells

F Rohwer, S Todd and KL McGuire
Department of Biology, Molecular Biology Institute, San Diego State University, CA 92182, USA.

IL-2 is the major mitogenic cytokine for mature human T cells. This growth factor has been shown previously to induce the expression of a number of genes, including structural proteins, proto-oncogenes, and metabolic enzymes. Multiple mechanisms, including increases in mRNA stability, protein synthesis, and new transcriptional initiation, have been studied to determine how IL-2 induces such a wide variety of genes. The following studies show that a release of transcriptional attenuation is important in IL-2-induced gene expression. A thymic blast cell system was developed and used to demonstrate that IL-2- deprived cells have a marked attenuation of transcription in the 3' ends of the pim-1 and c-myb genes. IL-2 stimulation removes this attenuation and leads to read-through transcription. This effect is gene-specific, as demonstrated by the fact that GAPDH is not attenuated in unstimulated cells. The IL-2-mediated relief of attenuation occurs within 1 h of IL-2 stimulation and is insensitive to the translation inhibitor cycloheximide, suggesting that new protein synthesis is not necessary. Further, the effect is insensitive to the immunosuppressant cyclosporin A, but is sensitive to rapamycin and the tyrosine kinase inhibitor genistein. These studies demonstrate that release of transcription attenuation is a mechanism used to induce gene expression in response to IL-2 treatment.

This article has been cited by other articles:

				Y. K. Lieu, A. Kumar, A. G. Pajerowski, T. J. Rogers, and E. P. Reddy Requirement of c-myb in T cell development and in mature T cell function PNAS, October 12, 2004; 101(41): 14853 - 14858. [Abstract] [Full Text] [PDF]

				N. Zhu, L. M. Ramirez, R. L. Lee, N. S. Magnuson, G. A. Bishop, and M. R. Gold CD40 Signaling in B Cells Regulates the Expression of the Pim-1 Kinase Via the NF-{kappa}B Pathway J. Immunol., January 15, 2002; 168(2): 744 - 754. [Abstract] [Full Text] [PDF]

				A. Lauder, A. Castellanos, and K. Weston c-myb Transcription Is Activated by Protein Kinase B (PKB) following Interleukin 2 Stimulation of T Cells and Is Required for PKB-Mediated Protection from Apoptosis Mol. Cell. Biol., September 1, 2001; 21(17): 5797 - 5805. [Abstract] [Full Text] [PDF]

				H. Jacobs, P. Krimpenfort, M. Haks, J. Allen, B. Blom, C. Demolliere, A. Kruisbeek, H. Spits, and A. Berns PIM1 Reconstitutes Thymus Cellularity in Interleukin 7- and Common {gamma} Chain-Mutant Mice and Permits Thymocyte Maturation in Rag- but Not CD3{gamma}-deficient Mice J. Exp. Med., October 18, 1999; 190(8): 1059 - 1068. [Abstract] [Full Text] [PDF]

				M. Iacobelli, F. Rohwer, P. Shanahan, J. A. Quiroz, and K. L. McGuire IL-2-Mediated Cell Cycle Progression and Inhibition of Apoptosis Does Not Require NF-{kappa}B or Activating Protein-1 Activation in Primary Human T Cells J. Immunol., March 15, 1999; 162(6): 3308 - 3315. [Abstract] [Full Text] [PDF]